Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antipsychotic and Psychostimulant Drug Combination Therapy in Attention Deficit/Hyperactivity and Disruptive Behavior Disorders: A Systematic Review of Efficacy and Tolerability
David Linton, Alasdair M. Barr, William G. Honer, et al.
Current Psychiatry Reports (2013) Vol. 15, Iss. 5
Closed Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Practitioner Review: Psychological treatments for children and adolescents with conduct disorder problems – a systematic review and meta‐analysis
Mireille J. Bakker, Corina U. Greven, Jan K. Buitelaar, et al.
Journal of Child Psychology and Psychiatry (2016) Vol. 58, Iss. 1, pp. 4-18
Closed Access | Times Cited: 105
A Focused Review of the Metabolic Side-Effects of Clozapine
Jessica W. Y. Yuen, David D. Kim, Ric M. Procyshyn, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 53
Long-acting injectable antipsychotics for early psychosis: A comprehensive systematic review
Lulu Lian, David D. Kim, Ric M. Procyshyn, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0267808-e0267808
Open Access | Times Cited: 28
Growth in the Concurrent Use of Antipsychotics With Other Psychotropic Medications in Medicaid-Enrolled Children
Amanda R. Kreider, Meredith Matone, Christopher Bellonci, et al.
Journal of the American Academy of Child & Adolescent Psychiatry (2014) Vol. 53, Iss. 9, pp. 960-970.e2
Closed Access | Times Cited: 62
Duration of Neurocognitive Impairment With Medical Cannabis Use: A Scoping Review
Lauren Eadie, Lindsay A. Lo, April Christiansen, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 35
Efficacy of long‐acting injectable versus oral antipsychotic drugs in early psychosis: A systematic review and meta‐analysis
Lulu Lian, David D. Kim, Ric M. Procyshyn, et al.
Early Intervention in Psychiatry (2021) Vol. 16, Iss. 6, pp. 589-599
Closed Access | Times Cited: 35
Pharmacotherapy of Aggression in Child and Adolescent Psychiatric Disorders
Tina Gurnani, Iliyan Ivanov, Jeffrey H. Newcorn
Journal of Child and Adolescent Psychopharmacology (2016) Vol. 26, Iss. 1, pp. 65-73
Closed Access | Times Cited: 44
Current nonstimulant medications for adults with attention-deficit/hyperactivity disorder
Giulio Emilio Brancati, Anna Magnesa, Donatella Acierno, et al.
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 8, pp. 743-759
Closed Access | Times Cited: 4
The Role of Methylphenidate and Aripiprazole in the Treatment of Emotion Dysregulation in Children With ADHD
Pei‐Yin Pan, Chin‐Bin Yeh
Journal of Clinical Psychopharmacology (2025)
Closed Access
Psychotropic Polypharmacy Among Children and Youth Receiving Medicaid, 2012-2015
William David Lohr, Liza Creel, Yana Feygin, et al.
Journal of Managed Care & Specialty Pharmacy (2018) Vol. 24, Iss. 8, pp. 736-744
Open Access | Times Cited: 35
Outpatient antipsychotic drug use in children and adolescents in Germany between 2004 and 2011
Carsten Schröder, Michael Dörks, Bianca Kollhorst, et al.
European Child & Adolescent Psychiatry (2016) Vol. 26, Iss. 4, pp. 413-420
Closed Access | Times Cited: 32
DSM-5: Disruptive mood dysregulation disorder
Uma Rao
Asian Journal of Psychiatry (2014) Vol. 11, pp. 119-123
Open Access | Times Cited: 31
Therapeutic Drug Levels of Second Generation Antipsychotics in Youth: A Systematic Review
Zachary Whitney, Heidi N. Boyda, Ric M. Procyshyn, et al.
Journal of Child and Adolescent Psychopharmacology (2015) Vol. 25, Iss. 3, pp. 234-245
Closed Access | Times Cited: 28
Differential Effects of Acute Treatment With Antipsychotic Drugs on Peripheral Catecholamines
Heidi N. Boyda, Amanzo A. Ho, Lurdes Tse, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 22
Safety and tolerability of antipsychotic agents in neurodevelopmental disorders: a systematic review
Felice Iasevoli, Annarita Barone, Elisabetta Filomena Buonaguro, et al.
Expert Opinion on Drug Safety (2020) Vol. 19, Iss. 11, pp. 1419-1444
Closed Access | Times Cited: 21
Pharmacological management of agitation among individuals with moderate to severe acquired brain injury: A systematic review
Swati Mehta, Amanda McIntyre, Shannon Janzen, et al.
Brain Injury (2018) Vol. 32, Iss. 3, pp. 287-296
Closed Access | Times Cited: 21
A cross sectional study of psychotropic medicine use in Australia in 2018: A focus on polypharmacy
Jonathan Brett, Sallie‐Anne Pearson, Benjamin Daniels, et al.
British Journal of Clinical Pharmacology (2020) Vol. 87, Iss. 3, pp. 1369-1377
Open Access | Times Cited: 16
Improving Metabolic and Cardiovascular Health at an Early Psychosis Intervention Program in Vancouver, Canada
Diane Fredrikson, Heidi N. Boyda, Lurdes Tse, et al.
Frontiers in Psychiatry (2014) Vol. 5
Open Access | Times Cited: 17
Long-Term Metabolic Effects in French-Canadian Children and Adolescents Treated with Second-Generation Antipsychotics in Monotherapy or Polytherapy: A 24-Month Descriptive Retrospective Study
Drigissa Ilies, Anne-Sophie Huet, Éric Lacourse, et al.
The Canadian Journal of Psychiatry (2017) Vol. 62, Iss. 12, pp. 827-836
Open Access | Times Cited: 16
Behavioral Weight Loss Treatment for Youth Treated With Antipsychotic Medications
Ginger E. Nicol, Rachel P. Kolko, Monica Mills, et al.
Scandinavian Journal of Child and Adolescent Psychiatry and Psychology (2016) Vol. 4, Iss. 2, pp. 96-104
Open Access | Times Cited: 13
Use and Characteristics of Antipsychotic/Methylphenidate Combination Therapy in Children and Adolescents with a Diagnosis of Attention-Deficit/Hyperactivity Disorder
Oliver Scholle, Tobias Banaschewski, Dirk Enders, et al.
Journal of Child and Adolescent Psychopharmacology (2018) Vol. 28, Iss. 6, pp. 415-422
Open Access | Times Cited: 14
Combining stimulants with antipsychotics for foster children and adolescents: Do prescribers adhere to guidelines?
Helena Bush, John T. Rapp, Erica D. Kierce
Children and Youth Services Review (2020) Vol. 121, pp. 105902-105902
Closed Access | Times Cited: 12
Foetal alcohol spectrum disorder (FASD) – its relevance to forensic adolescent services
Ernest Gralton
Journal of Intellectual Disabilities and Offending Behaviour (2014) Vol. 5, Iss. 3, pp. 124-137
Closed Access | Times Cited: 11
Extent and Risks of Antipsychotic Off-Label Use in Children and Adolescents in Germany Between 2004 and 2011
Carsten Schröder, Michael Dörks, Bianca Kollhorst, et al.
Journal of Child and Adolescent Psychopharmacology (2017) Vol. 27, Iss. 9, pp. 806-813
Open Access | Times Cited: 11
Combined stimulant and antipsychotic treatment in adolescents with attention-deficit/hyperactivity disorder: a cross-sectional observational structural MRI study
Lizanne Schweren, Catharina A. Hartman, Marcel P. Zwiers, et al.
European Child & Adolescent Psychiatry (2014) Vol. 24, Iss. 8, pp. 959-968
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top